Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.
3.

Long-term effects of percutaneous estrogens and oral progesterone on serum lipoproteins in postmenopausal women.

Jensen J, Riis BJ, Strøm V, Nilas L, Christiansen C.

Am J Obstet Gynecol. 1987 Jan;156(1):66-71.

PMID:
3541623
4.

Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.

Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.

Metabolism. 2009 Jan;58(1):1-7. doi: 10.1016/j.metabol.2008.07.016.

PMID:
19059524
5.
6.

Continuous oestrogen-progestogen treatment and serum lipoproteins in postmenopausal women.

Jensen J, Riis BJ, Strøm V, Christiansen C.

Br J Obstet Gynaecol. 1987 Feb;94(2):130-5.

PMID:
3828253
7.

Short-term effects of smoking on the pharmacokinetic profiles of micronized estradiol in postmenopausal women.

Cassidenti DL, Vijod AG, Vijod MA, Stanczyk FZ, Lobo RA.

Am J Obstet Gynecol. 1990 Dec;163(6 Pt 1):1953-60.

PMID:
2256508
8.
9.

Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause.

Jensen J, Christiansen C, Rødbro P.

N Engl J Med. 1985 Oct 17;313(16):973-5.

PMID:
4047104
10.

The effects of transdermal estrogen therapy on bone mass and turnover in early postmenopausal smokers: a prospective, controlled study.

Välimäki MJ, Laitinen KA, Tähtelä RK, Hirvonen EJ, Risteli JP.

Am J Obstet Gynecol. 2003 Nov;189(5):1213-20.

PMID:
14634543
11.

Changes in lipids and lipoproteins with long-term estrogen deficiency and hormone replacement therapy.

Gambrell RD Jr, Teran AZ.

Am J Obstet Gynecol. 1991 Aug;165(2):307-15; discussion 315-7.

PMID:
1872331
12.

Effects of estrogen dose and smoking on lipid and lipoprotein levels in postmenopausal women.

Krauss RM, Perlman JA, Ray R, Petitti D.

Am J Obstet Gynecol. 1988 Jun;158(6 Pt 2):1606-11.

PMID:
2837088
13.

Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.

Jirapinyo M, Theppisai U, Manonai J, Suchartwatnachai C, Jorgensen LN.

Acta Obstet Gynecol Scand. 2003 Sep;82(9):857-66.

PMID:
12911449
14.

Long-term effects of transdermal and oral estrogens on serum lipids and lipoproteins in postmenopausal women.

Adami S, Rossini M, Zamberlan N, Bertoldo F, Dorizzi R, Lo Cascio V.

Maturitas. 1993 Nov;17(3):191-6.

PMID:
8133793
15.

Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.

Vehkavaara S, Silveira A, Hakala-Ala-Pietilä T, Virkamäki A, Hovatta O, Hamsten A, Taskinen MR, Yki-Järvinen H.

Thromb Haemost. 2001 Apr;85(4):619-25.

PMID:
11341495
16.

The relation of endogenous sex steroid hormone concentrations to serum lipid and lipoprotein levels in postmenopausal women.

Cauley JA, Gutai JP, Kuller LH, Powell JG.

Am J Epidemiol. 1990 Nov;132(5):884-94.

PMID:
2239903
17.
18.

Is the response of serum lipids and lipoproteins to postmenopausal hormone replacement therapy modified by ApoE genotype?

Heikkinen AM, Niskanen L, Ryynänen M, Komulainen MH, Tuppurainen MT, Parviainen M, Saarikoski S.

Arterioscler Thromb Vasc Biol. 1999 Feb;19(2):402-7.

19.
20.

Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.

Vrablik M, Fait T, Kovar J, Poledne R, Ceska R.

Metabolism. 2008 Aug;57(8):1088-92. doi: 10.1016/j.metabol.2008.03.012.

PMID:
18640386

Supplemental Content

Support Center